149
CHAPTER 10
REFERENCES
1. Balasubramanian, D., Bansal, A. K., Basti, S., Bhatt, K. S., 1993, “Current
Ophthalmology. The Biology of Cataract. The Hyderabad Cataract Research
Group,” Indian Journal of Ophthalmology., 41, pp. 33-47.
2. Dobson, R., 2005, “Ozone Depletion Will Bring Big Rise in Number of
Cataracts,” British Medical Journal., 331(7528), pp. 1292.
3. WHO. Available Data on Blindness (update 1987) WHO/Pbl/87.14. WHO,
Geneva.
4. Foster, A., 2001, “Cataract and "Vision 2020-The Right to Sight" Initiative,”
British Journal of Ophthalmology., 85, pp. 635-639.
5. Minassian, D. C., Mehra V., 1990, “3.8 Million Blinded by Cataract Each Year.
Projections From the First Epidemiological Study of Incidence of Cataract
Blindness in India,” British Journal of Ophthalmology., 74, pp. 341-343.
6. Foster, A., 2000, “Vision 2020: The Cataract Challenge,” Community Eye Health.,
13, pp. 17-21.
7. Beebe, D., 2003, “The Lens: Adler's Physiology of the Eye,” 10th
Edition, A.A.
Kaufman Publications, St Louis, Mosby.
8. Bhat, S., 2001, “The Ocular Lens Epithelium,” Bioscience Reports., 21, pp. 537-
563.
9. Francis, P., Berry, V., Moore, A., Bhattacharya, S., 1999, “Lens Biology:
Development and Human Cataractogenesis,” Trends in Genetics., 15, pp. 191-196.
10. Bunce, G. E., 1994b, “Nutrition and Eye Disease of the Elderly,” Journal of
Nutritional Biochemistry., 5(1), pp. 66-77.
11. Spector, A., 1984, “The Search for a Solution to Senile Cataracts,” Investigative
Ophthalmology and Visual Sciences., 25(2), pp. 130-146.
12. Harrington, V., McCall, S., Huynh, S., Srivastava, K., Srivastava, O. P., 2004,
“Crystallins in Water Soluble-high Molecular Weight Protein Fractions and Water
150
Insoluble Protein Fractions in Aging and Cataractous Lenses,” Molecular Vision.,
10, pp. 476-489.
13. Marcantonio, J. M., Duncan, G., Rink, H., 1986, “Calcium-induced Opacification
and Loss of Protein in the Organ-cultured Bovine Lens,” Experimental Eye
Research., 42, pp. 617-630.
14. Sulochana, K. N., Punitham, R., Ramakrishnan, S., 2002, “Effect of Cigarette
Smoking on Cataract: Antioxidant Enzymes and Constituent Minerals in the Lens
and Blood of Humans,” Indian Journal of Pharmacology., 34, pp. 428-431.
15. Aksoy, H., Keles, S., Kocer, I., Akcay, F., 2001, “Diabetic Cataract and the Total
Antioxidant Status in Aqueous Humor,” Clinical Chemistry Laboratory Medicine.,
39, pp. 143-145.
16. Christine, Y., Paul, M., Robert, G. C., Panchapakesan, J., Elena, R., Angela, M.
H., 2002, “Hormone Replacement Therapy, Reproductive Factors, and the
Incidence of Cataract and Cataract Surgery: The Blue Mountains Eye Study,”
American Journal of Epidemiology., 155, pp. 997-1006.
17. Jaime, E. D., Dotzel, E., Abbot, F. L., 1997, “Steroid Induced Cataract: New
Perspectives from in vitro and Lens Culture Studies,” Experiment Eye Research.,
65, pp. 507-516.
18. Varma, S. D., Hegde, K. R., 2007, “Susceptibility of the Ocular Lens to Nitric
Oxide: Implications in Cataractogenesis,” Journal of Ocular Pharmacology and
Therapeutics., 23, pp. 188-195.
19. Harding, J., 1991, “Cataract: Biochemistry, Epidemiology and Pharmacology,”
Chapman-Hall, London, pp. 83-124.
20. Clark, J. I., 1994, “Development and Maintenance of Lens Transparency” In:
Albers, E. M., Jakobiec, F. A., editors. “Principles and Practice of
Ophthalmology,” W. B. Saunders, Philadelphia, pp. 114-123.
21. Ito, Y., Nabekura, T., Takeda, M., Nakao, M., Terao, M., Hori, R., 2001, “Nitric
Oxide Participates in Cataract Development in Selenite Treated rats,” Current Eye
Research., 22, pp. 215-220.
22. Monnier, V. M., Sell., D. R.., Nagaraj, R. H., Miyata, S., Grandhee, S., Odetti, P.,
1992, “Maillard Reaction-mediated Molecular Damage to Extracellular Matrix
and Other Tissue Proteins in Diabetes, Ageing and Uremia,” Diabetes., 41, pp. 36-
41.
151
23. Duhaiman, A. S., 1995, “Glycation of Human Lens Proteins from Diabetic and
Non-diabetic Senile Cataract Patients,” Glycoconjugate Journal., 12, pp. 618-621.
24. Sies, H., 1991, “Oxidative Stress II. Oxidants and Antioxidants,” Academic Press,
London.
25. Spector, A., 1995, “Oxidative Stress-induced Cataract: Mechanism of Action,”
FASEB., 9, pp. 1173-1182.
26. Slaughter, M. R., Thakkar, H., O'Brien, P. J., 2002, “Effect of Diquat on the
Antioxidant System and Cell Growth in Human Neuroblastoma Cells,”
Toxicology and Applied Pharmacology., 178(2), pp. 63-70.
27. Lou, M. F., 2003, “Redox Regulation in the Lens,” Progress in Retina and Eye
Research., 22(5), pp. 657-682.
28. Zigler, J. S., Bodaness, R. S., Gery, I., Kinoshita, J. H., 1983, “Effects of Lipid
Peroxidation Products on the Rat Lens in Organ Culture: A Possible Mechanism
of Cataract Initiation in Retinal Degenerative Disease,” Archives of Biochemistry
and Biophysics., 225(1), pp. 149-156.
29. Kleiman, N. J., Wang, R. R., Spector, A., 1990, “Hydrogen Peroxide-induced
DNA Damage in Bovine Lens Epithelial Cells,” Mutation Research., 240(1), pp.
35-45.
30. Cui, X. L., Lou, M. F., 1993, “The Effect and Recovery of Long-term H2O2
Exposure on Lens Morphology and Biochemistry,” Experimental Eye Research.,
57(2), pp. 157-167.
31. Mates, J. M., Sanchez-Jimenez, F., 1999, “Antioxidant Enzymes and Their
Implications in Pathophysiologic Processes,” Frontier Bioscience., 4, pp. D339-
345.
32. Altomare, E., Vendemiale, G., Grattagliano, I., Angelini, P., Micelli-Ferrari, T.,
Cardia, L., 1995, “Human Diabetic Cataract: Role of Lipid Peroxidation,”
Diabetes Metabolism., 21(3), pp. 173-179.
33. Spector, A., 2000, “Review: Oxidative Stress and Disease,” Journal of Ocular
Pharmacology and Therapeutics., 16(2), pp. 193-201.
34. Zigman, S., 2000, “Lens UVA Photobiology,” Journal of Ocular Pharmacology
and Therapeutics., 16(2), pp. 161-165.
152
35. Sanderson, J., Mclauchlan, W. R., Williamson, G., 1999, “Quercetin Inhibits
Hydrogen Peroxide-induced Oxidation of the Rat Lens,” Free Radical Biology and
Medicine., 26, pp. 639-645.
36. Slaughter, M. R., Thakkar, H., O'Brien, P. J., 2003, “Differential Expression of the
Lenticular Antioxidant System in Laboratory Animals: A Determinant of Species
Predilection to Oxidative Stress-induced Ocular Toxicity,” Current Eye Research.,
26, pp. 15-23.
37. Srikanthan, D., Bateman, O. A., Purkiss, A. G., Slingsby, C., 2004, “Sulfur in
Human Crystallins,” Experimental Eye Research., 79, pp. 823-831.
38. Halliwell, B., Gutteridge, J. M. C., 1999, “Free Radicals in Biology and
Medicine,” Oxford University Press Inc, New York.
39. Garner, M. H., Spector, A., 1980, “Selective Oxidation of Cysteine and
Methionine in Normal and Senile Cataractous Lenses,” Proceedings of the
National Academy of Sciences of the United States of America., 77, pp. 1274-
1277.
40. Truscott, R. J., Augusteyn, R. C., 1977, “Oxidative Changes in Human Lens
Proteins During Senile Nuclear Cataract Formation,” Biochimica et Biophysica
Acta., 492, pp. 43-52.
41. Truscott, R. J., 2005, “Age-related Nuclear Cataract: Oxidation is the Key,”
Experimental Eye Research., 80, pp. 709-725.
42. Taylor, A., Davies, K. J., 1987, “Protein Oxidation and Loss of Protease Activity
may lead to Cataract Formation in the Aged Lens,” Free Radical Biology and
Medicine., 3, pp. 371-377.
43. Davies, M. J., Truscott, R. J., 2001, “Photo-oxidation of Proteins and its role in
Cataractogenesis,” Journal of Photochemistry and Photobiology B., 63, pp. 114-
125.
44. Anderson, M. E., 1985, “Determination of Glutathione and Glutathione Disulfide
in Biological Samples,” Methods in Enzymology., 113: 548-555.
45. Meister, A., 1983, “Selective Modification of Glutathione Metabolism,” Science.,
220, pp. 472-477.
46. Tarwadi, K., Agte, V., 2004, “Linkage of Antioxidant, Micronutrient, and
Socioeconomic Status with the Degree of Oxidative Stress and Lens Opacity in
Indian Cataract Patients,” Nutrition., 20, pp. 261-267.
153
47. Roberts, J. E., 2001, “Ocular Phototoxicity,” Journal of Photochemistry and
Photobiology B: Biology., 64, pp. 136-143.
48. Blondin, J., Baragi, V., Schwartz, E., Sadowski, J. A., Taylor, A., 1986, “Delay of
UV-induced Eye Lens Protein Damage in Guinea Pigs by Dietary Ascorbate,”
Journal of Free Radical Biology and Medicine., 2, pp. 275-281.
49. Reddan, J. R., Sevilla, M. D., Giblin, F. J., Padgaonkar, V., Dziedzic, D. C.,
Leverenz, V., Misra, I. C., Peters, J. L., 1993, “The Superoxide Dismutase Mimic
TEMPOL Protects Cultured Rabbit Lens Epithelial Cells from Hydrogen Peroxide
Insult,” Experimental Eye Research., 56, pp. 543-554.
50. Spector, A., Kleiman, N. J., Huang, R. R., Wang, R. R., 1989, “Repair of H2O2-
induced DNA Damage in Bovine Lens Epithelial Cell Cultures,” Experimental
Eye Research., 49, pp. 685-698.
51. Shang, F., Gong, X., Taylor, A., 1997, “Activity of Ubiquitin-dependent Pathway
in Response to Oxidative Stress,” The Journal of Biological Chemistry., 272, pp.
23086-23093.
52. Andley, U. P., Rhim, J. S., Chylack Jr, L. T., Fleming, T. P., 1994, “Propagation
and Immortalization of Human Lens Epithelial Cells in Culture,” Investigative
Ophthalmology and Visual Sciences., 35, pp. 3094-3102.
53. Ahuja, R. P., Borchman, D., Dean, W. L., Paterson, C. A., Zeng, J., Zhang, Z.,
Ferguson- Yankey, S., Yappert, M. C., 1999, “Effect of Oxidation on Ca2+
-
ATPase Activity and Membrane Lipids in Lens Epithelial Microsomes,” Free
Radical Biology and Medicine., 27, pp. 177-185.
54. Babizhayev, M. A., Deyev, A. I., Linberg, L. F., 1988, “Lipid Peroxidation as a
Possible Cause of Cataract,” Mechanisms of Ageing and Development., 44, pp.
69-89.
55. Jedziniak, J. A., Kinoshita, J. H., Yates, E. M., Hocker, L. O., Benedek, G. B.,
1972, “Calcium Induced Aggregation of Bovine Lens alpha Crystallins,”
Investigative Ophthalmology and Visual Sciences., 11, pp. 905-915.
56. Delamere, N. A., Paterson, C. A., Borchman, D., Manning, R. E., 1993, “The
Influence of Calcium on the Rabbit Lens Sodium Pump,” Investigative
Ophthalmology and Visual Sciences., 34, pp. 405-412.
57. Hightower, K. R., Duncan, G., Harrison, S. E., 1985, “Intracellular Calcium
Concentration and Calcium Transport in the Rabbit Lens,” Investigative
Ophthalmology and Visual Sciences., 26, pp. 1032-1034.
154
58. Tamada, Y., Fukiage, C., Nakamura, Y., Azyma, M., Kim, Y. H., Shearer, T. R.,
2000, “Evidence for Apoptosis in the Selenite Rat Model of Cataract,”
Biochemical and Biophysical Research Communications., 275, pp. 300-306.
59. Zigler, J. S., Qin, C., Kamiya, T., Krishna, M. C., Cheng, Q. F., Tumminia, S.,
Russell, P., 2003, “Tempol-H Inhibits Opacification of Lenses in Organ Culture,”
Free Radical Biology and Medicine., 35, pp. 1194-1202.
60. Obin, M., Shang, F., Gong, X., Handelman, G., Blumberg, J., Taylor, A., 1998,
“Redox Regulation of Ubiquitin-conjugating Enzymes: Mechanistic Insights
Using the Thiol Specific Oxidant Diamide,” FASEB Journal., 12, pp. 561-569.
61. Lou, M. F., Dickerson, J. E., Jr., Garadi, R., 1990, “The Role of Protein-thiol
Mixed Disulfides in Cataractogenesis,” Experimental Eye Research., 50, pp. 819-
826.
62. Zenon, G. J., Abobo, C. V., Carter, B. L., Ball, D. W., 1990, “Potential Use of
Aldose Reductase Inhibitors to Prevent Diabetic Complications,” Clinical
Pharmacy., 9, pp. 446-457.
63. Nakai, N., Fujii, Y., Kobashi, K., Nomura, K., 1985, “Aldose Reductase
Inhibitors: Flavonoids, Alkaloids, Acetophenones, Benzophenones, and
Spirohydantoins of Chroman,” Archives of Biochemistry and Biophysics., 239,
pp. 491-496.
64. Varma, S. D., Mikuni, I., Kinoshita J. H., 1975, “Flavonoids as Inhibitors of Lens
Aldose Reductase,” Science., 188, pp. 1215-1216.
65. Mohan, M., Gupta, S. K., Agnihotri, S., Joshi, S., Uppal, R. K., 1988,
“Anticataract Action of Topical Quercetin and Myricetin in Galactosemic Rats,”
Medical Science Research., 16, pp. 685-686.
66. Kathleen, N. D., 2001, “Natural Therapies for Ocular Disorders: Cataracts and
Glaucoma,” Alternative Medicine Review., 6, pp. 141-166.
67. Sanghyun, L., Sang, H. S., Kim, J. S., Shin, K. H., Kang, S. S., 2005, “Aldose
Reductase Inhibitors from the Fruiting Bodies of Ganoderma applanatum,”
Biological and Pharmaceutical Bulletin., 28, pp. 1103-1105.
68. Varma, S. D., Hegde, K. R., 2005, “Prevention of Cataract by Pyruvate in
Experimentally Diabetic Mice,” Molecular Cell Biochemistry., 269, pp. 115-120.
69. Suryanarayana, P., Kumar, A. P., Saraswat, M., Mark, P., Reddy, G. B., 2004,
“Inhibition of Aldose Reductase by Tannoid Principles of Emblica officinalis:
155
Implications for the Prevention of Sugar Cataract,” Molecular Vision., 10, pp.
148-154.
70. Yokoyama, T., Sasake, H., Giblin, F. J., Reddy V. N., 1994, “A Physiological
Level of Ascorbate Inhibits Galactose Cataracts in Guinea Pigs by Decreasing
Polyol Accumulation in the Lens Epithelium: A Dehydro Ascorbate Linked
Mechanism,” Experimental Eye Research., 58, pp. 207-218.
71. Cunningham, J. J., Mearkle, P. L., Brown, R. G., 1994, “Vitamin C: An Aldose
Reductase Inhibitor that Normalizes Erythrocyte Sorbitol in Insulin Dependent
Diabetes Mellitus,” Journal of the American College of Nutrition., 13, pp. 344-
350.
72. Moghaddam, M. S., Kumar, P. A., Reddy, G. B., Ghole, V. S., 2005, “Effect of
Diabecon on Sugar-induced Lens Opacity in Organ Culture: Mechanism of
Action,” Journal of Ethnopharmacology., 97, pp. 397-403.
73. Egerton, M., Harding, R. S., 1989, “Protection Against Cataract by Aspirin,
Paracetamol, and Ibuprofen,” Acta Ophthalmologica., 67, pp. 518-524.
74. Gupta, S. K., Joshi, S., 1991, “Naproxen: An Aldose Reductase Inhibitor and
Potential Anti-cataract Agent,” Developments in Ophthalmology., 21, pp. 171-
178.
75. Gupta, S. K., Joshi, S., 1994, “Role of Naproxen as Antioxidant in Selenite
Cataract,” Ophthalmic Research., 26, pp. 226-231.
76. Gupta, S. K., Joshi, S., 1993, “Prevention of Photo Peroxidation of Lens Lipids by
Naproxen,” Afro Asian Journal of Ophthalmology., 12, pp. 295-297.
77. Gupta, S. K., Agnihotri, S., Joshi, S., 1989, “Anti-cataract Action of Topical
Sulindac in Galactosemic Rats,” Afro Asian Journal of Ophthalmology., 8, pp. 57-
61.
78. Varma, S. D., Hegde, K. R., 2004, “Effect of α-ketoglutarate Against Selenite
Cataract Formation,” Experimental Eye Research., 79, pp. 913-918.
79. Gupta, S. K., Mohanty, I., Joshi, S., Trivedi, D., Srivastava, S., 2002, “Lycopene
Prevents Sugar-induced Morphological Changes and Modulates Antioxidant
Status of Human Lens Epithelial Cells,” British Journal of Nutrition., 88, pp. 347-
354.
80. Ayala, M. N., Soderberg, P. G., 2004, “Vitamin C can Protect Against Ultraviolet
Radiation Induced Cataract in Albino Rats,” Ophthalmic Research., 36, pp. 264-
269.
156
81. Abe, M., Reiter, R. J., Orhii, P. B., Hara, M., Poeggeler, B., 1994, “Inhibitory
Effect of Melatonin on Cataract Formation in Newborn Rats: Evidence for an
Antioxidative Role for Melatonin,” Journal of Pineal Research., 17, pp. 94-100.
82. Hockwin, O., Weigelin, E., Baur, M., Boutros G., 1982, “Kontrollietre Klinische
Studie Uber Die Wirksankeit Von Phaken als Anti-kataract Medicament,”
Fortschritte der Ophthalmologie., 79, pp. 179-183.
83. David, L. W., 2006, “Oxidation, Antioxidants and Cataract Formation: A
Literature Review,” Veterinary Ophthalmology., 9, pp. 292-298.
84. Ohta, Y., Niwa, T., Yamasaki, T., 2001, “Effect of Prolonged Marginal Ascorbic
Acid Deficiency on Lenticular Levels of Antioxidants and Lipid Peroxide in
Guinea Pig,” International Journal of Vitamin and Nutritional Research., 71, pp.
103-109.
85. Saxena, P., Saxena, A. K., Monnier, V. M., 1996, “High Galactose Levels in vitro
and in vivo Impair Ascorbate Regeneration and Increase Ascorbate-mediated
Glycation in Cultured Rat Lens,” Experimental Eye Research., 63, pp. 535-545.
86. Mody, V. C., Kakar, M., Elfving, A., Soderberg, P. G., Lofgren, S., 2005,
“Ascorbate in the Rat Lens: Dependence on Dietary Intake,” Ophthalmic
Research., 37, pp. 142-149.
87. Labgle, U. W., Wolf, A., Cordier, A., 1997, “Enhancement of SDZ ICT 322-
induced Cataracts and Skin Changes in Rats following Vitamin E and Selenium
Deficient Diet,” Archives of Toxicology., 71, pp. 283-289.
88. Kojima, M., Shui, Y. B., Murano, M., Nagata, O., Hockwin, K., Sasaki, K., 2002,
“Low Vitamin E Level as a Subliminal Risk Factor in a Rat Model of Predisolone-
induced Cataract,” Investigative Ophthalmology and Visual Sciences., 43, pp.
1116-1120.
89. Reddy, G. B., Nayak, S., Reddy, P. Y., Seetharam, K., 2001, “Reduced Levels of
Rat Lens Antioxidant Vitamins Upon in vitro UVB Irradiation,” Journal of
Nutrition Biochemistry., 12, pp. 121-124.
90. Horwitz, J., Dovrat, A., Straatsma, B. E., Revilla, P. J., Lightfoot, D. O., 1987,
“Glutathione Reductase in Human Lens Epithelium: FAD-induced in vitro
Activation,” Current Eye Research., 6, pp. 1249-1256.
91. Bhat, K. S., 1987, “Nutritional Status of Thiamine, Riboflavin and Pyridoxine in
Cataract Patients,” Nutrition Reports International., 36, pp. 685-692.
157
92. Karakucuk, S., Ertugrul Mirza, G., Faruk Ekinciler, O., Saraymen, R., Karakucuk,
I., Ustdal, M., 1995, “Selenium Concentrations in Serum, Lens and Aqueous
Humor of Patients with Senile Cataract,” Acta Ophthalmologica., 73, pp. 329-332.
93. Cumming, R. G., Mitchell, P., Smith, W., 2000, “Diet and Cataract: The Blue
Mountains Eye Studies,” Ophthalmology., 107, pp. 450-456.
94. Mares-Perlman, J. A., Brady, W. E., Klein, B. E., Klein, R., Haus, G. J., Palta, M.,
1995, “Diet and Nuclear Lens Opacities,” Americal Journal of Epidemiology., 41,
pp. 322-334.
95. Clinton, S. K., 1998, “Lycopene: Chemistry, Biology and Implications for Human
Health and Disease,” Nutrition Review., 56, pp. 35-51.
96. Gupta, S. K., Trivedi, D., Srivastava, S., Joshi, S., Halder, N., Varma S. D., 2003,
“Lycopene Attenuates Oxidative Stress Induced Experimental Cataract
Development: An in vitro and in vivo Study,” Nutrition., 19, pp. 794-799.
97. Rao, K. E., 1990, “Oxygen Radical Scavenging Activity of Curcumin,”
International Journal of Pharmacology., 58, pp. 237-240.
98. Suryanarayana, P., Krishnaswamy, K., Reddy, G. B., 2003, “Effect of Curcumin
on Galactose-induced Cataractogenesis in Rat,” Molecular Vision., 9, pp. 223-
230.
99. Suryanaraya, P., Saraswat, M., Mrudula, T., Krishna, T. P., Krishnaswamy, K.,
Reddy, G. B., 2005, “Curcumin and Turmeric Delay Streptozotocin Induced
Diabetic Cataract in Rats,” Investigative Ophthalmology and Visual Sciences., 46,
pp. 2092-2099.
100. Padmaja, S., Raju, T. N., 2004, “Antioxidant Effect of Curcumin in Selenium
Induced Cataract of Wistar Rats,” Indian Journal of Experimental Biology., 42, pp.
601-603.
101. Horakova, L., Stolc, S., 1998, “Antioxidant and Pharmacodynamic Effects of
Pyridoindole Stobadine,” General Pharmacology., 30, pp. 627-638.
102. Stefek, M., Krizanova, L., Trnkova, Z., 1999, “Oxidative Modification of Serum
Albumin in an Experimental Glycation Model of Diabetes Mellitus in vitro: Effect
of the Pyridoindole Antioxidant Stobadine,” Life Sciences., 65, pp. 1995-1997.
103. Kyselova, Z., Gajdosik, A., Gajdosikova, A., Uliena, O., Mihalova, D., Karasu, C.,
2005, “Effect of the Pyridoindole Antioxidant Stobadine on Development of
Experimental Diabetic Cataract and on Lens Protein Oxidation in Rats:
Comparison with Vitamin E and BHT,” Molecular Vision., 11, pp. 56-65.
158
104. Gupta, S. K., Srivastava, S., Trivedi, D., Joshi, S., Nabanita, H., 2005, “Ocimum
sanctum Modulates Selenite-induced Cataractogenic Changes and Prevents Rat
Lens Opacification,” Current Eye Research., 30, pp. 583-591.
105. Vats, V., Yadav, S. P., Biswas, N. R., Grover, J. K., 2004, “Anti-cataract Activity
of Pterocarpus marsupium bark and Trigonella foenum Seeds Extract in Alloxan
Diabetic Rats,” Journal of Ethnopharmacology., 93, pp. 289-294.
106. Durukan, A. H., Evereklioglu, C., Hurmeric, V., Kerimoglu, H., Erdurman, C.,
Bayraktar, M. Z., 2006, “Ingestion of IH636 Grape Seed Proanthocyanidin Extract
to Prevent Selenite-induced Oxidative Stress in Experimental Cataract,” Journal of
Cataract and Refractive Surgery., 32, pp. 1041-1045.
107. Lija, Y., Biju, P. G., Reeni, A., Cibin, T. R., Sahasranamam, V., Abraham, A.,
2006, “Modulation of Selenite Cataract by the Flavonoid Fraction of Emilia
sonchifolia in Experimental Animal Models,” Phytotherapy Research., 20, pp.
1092-1095.
108. Biju, P. G., Devi, V. G., Lija, Y., Abraham, A., 2007, “Protection Against Selenite
Cataract in Rat Lens by Drevogenin D: A Triterpenoid Aglycone from Dregea
volubilis,” Journal of Medicinal Food., 10, pp. 308-315.
109. Bravetti, G., 1989, “Preventive Medical Treatment of Senile Cataract with Vitamin
E and Anthocyanosides: Clinical Evaluation,” Annali de Ottalmologia e Clinica
Oculistica., 115, pp. 109.
110. Ertekin, M. V., Kocccer, I., Karslioglu, I., Taysi, S., Gepdiremen, A., Sezen O.,
2004, “Effects of Oral Ginkgo biloba Supplementation on Cataract Formation and
Oxidative Stress Occurring in Lenses of Rats Exposed to Total Cranium
Radiotherapy,” Japanese Journal of Ophthalmology., 48, pp. 499-502.
111. Gupta, S. K., Halder, N., Srivastava, S., Trivedi, D., Joshi, S., Varma, S. D., 2002,
“Green Tea (Camellia sinensis) Protects Against Selenite-induced Oxidative
Stress in Experimental Cataractogenesis,” Ophthalmic Research., 34, pp. 258-263.
112. Thiagarajan, G., Chandani, S., Sundari, C. S., Rao, S. H., Kulkarni, A. V.,
Balasubramanian, D., 2001, “An Oxidative Property of Green Tea and Black Tea
and Their Potential Ability to Retard the Progression of Eye Lens Cataract,”
Experimental Eye Research., 73, pp. 393-401.
113. Joe, A. V., Juan, Z., 2005, “Black and Green Tea Equally Inhibit Diabetic
Cataracts in a Streptozotocin-induced Rat Model of Diabetes,” Journal of
Agriculture Food Chemistry., 53, pp. 3710-3713.
159
114. Suryanarayana, P., Saraswat, J., Petrash, J. M., Reddy, G. B., 2007, “Emblica
officinalis and its Enriched Tannoids Delay Streptozotocin Induced Diabetic
Cataract in Rats,” Molecular Vision., 13, pp. 291-297.
115. Velpandian, T., Mathur, P., Sengupta, S., Gupta, S. K., 1998, “Preventive Effect of
Chyavanprash Against Steroid Induced Cataract in the Developing Chick
Embryo,” Phytotherapy Research., 12, pp. 320-323.
116. Zhao, W., Devamanoharan, P. S., Varma, S. D., 2002, “Diabetes Induced
Biochemical Changes in Rat Lens: Attenuation of Cataractogenesis by Pyruvate,”
Diabetes Obstetrics and Metabolism., 2, pp. 165-174.
117. Varma, S. D., Ramachandran, S., Devamanoharan, P. S., Morris, S. M., Ali, A. H.,
1995, “Prevention of Oxidative Damage to Rat Lens in vitro by pyruvate: Possible
Attenuation in vivo,” Current Eye Research., 14, pp. 643-649.
118. Maitra, I., Serbinova, E., Trischier, H., Packer, L., 1995, “Alpha-lipoic Acid
Prevents Buthionine Sulfoximine Induced Cataract Formation in Newborn Rats,”
Free Radical Biology and Medicine., 18, pp. 823-829.
119. Hiraoka, T., Clark, J. I., Thurston, G. M., 1996, “Effect of Selected Anticataract
Agents of Opacification in the Selenite Cataract Model,” Experimental Eye
Research., 62, pp. 11-19.
120. Kuck, J. F., Kuck, K. D., 1988, “The Emory Mouse Cataract: The Effects of
Cataractogenesis of Alpha-tocopherol, Penicillamine, Triethylenetetramine and
Mercapto-propionylglycine,” Journal of Ocular Pharmacology., 4, pp. 243-251.
121. Wang, Z., Hess, J. L., Bunce, G. E., 1992, “Deferoxamine Effect on Selenite-
induced Cataract Formation in Rats,” Investigative Ophthalmology and Visual
Sciences., 33, pp. 2511-2519.
122. Jose, R., 1992, “Strength and Weakness of NPCB and Strategies for their
Evaluation” In: Khosla, P. K., editor. “Community Ophthalmology: An Indian
perspective,” Proceedings of First National Workshop on Community
Ophthalmology, New Delhi. All India Institute of Medical Sciences, New Delhi.,
pp. 79-85.
123. Govantes, C., Marin, J., 1996, “Effect of Angiotensin Converting Enzyme
Inhibitors on Quality of Life in Hypertensive Patients: Pharmacodynamic Basis,”
Fundamental Clinical Pharmacology., 10, pp. 400-405.
124. Ferrari, R., Cargnoni, A., Curello, S., Ceconi, C., Boraso, A., Visioli, O., 1992,
“Protection of Ischemic Myocardium by the Converting Enzyme Inhibitor
160
Zofenopril: Insight into its Mechanism of Action,” Journal of Cardiovascular
Pharmacology., 20, pp. 694-604.
125. Liu, T. H., Beckman, J. S., Freeman, B. A., Hogan, E. L., Hsu, C. Y., 1989,
“Polyethylene Glycol Conjugated Superoxide Dismutase and Catalase Reduce
Ischemic Brain Injury,” American Journal of Physiology., 256, pp. 589-593.
126. Kohara, K., Mikami, H., Okuda, N., Higaki, J., Ogihara, T., 1993, “Angiotensin
Blockade and the Progression of Renal Damage in the Spontaneously
Hypertensive Rat,” Hypertension., 21, pp. 975-979.
127. Kabour, A., Henegar, J. R., Devineni, V. R., Janicki, J. S., 1995, “Prevention of
Angiotensin II Induced Myocyte Necrosis and Coronary Vascular Damage by
Lisinopril and Losartan in the Rat,” Cardiovascular Research., 29, pp. 543-548.
128. Richer, C., Giroux, B., Plouin, P. F., Maarek, B., Giudicelli, J. F., 1984,
“Captopril: Pharmacokinetics, Antihypertensive and Biological Effects in
Hypertensive Patients,” British Journal of Clinical Pharmacology., 17, pp. 243-
250.
129. Atlas, S. A., Case, D. B., Sealey, J. E., Laragh, J. H., McKinstry, D. N., 1979,
“Interruption of the Rennin Angiotensin System in Hypertensive Patients by
Captopril Induces Sustained Reduction in Aldosterone Secretion, Potassium
Retention and Natriuresis,” Hypertension., 1, pp. 274-280.
130. Vogh, B. P., Godma, D. R., 1989, “Effect of Inhibition of Angiotensin Converting
Enzyme and Carbonic Anhydrase on Fluid Production by Ciliary Process, Choroid
Plexus, and Pancreas,” Journal of Ocular Pharmacology., 5, pp. 303-311.
131. Chopra, M., McMurray, J., Stewart, J., Dargie, H. J., Smith, W. E., 1990, “Free
Radical Scavenging: A Potentially Beneficial Action of Thiol Containing
Angiotensin Converting Enzyme Inhibitors,” Biochemistry Society Transactions.,
18, pp. 1184-1185.
132. Bhuyan, K. C., Bhuyan, D. K., Santos, O., Podos, S. M., 1992, “Antioxidant and
Anticataractogenic Effects of Topical Captopril in Diquat Induced Cataract in
Rabbits,” Free Radical Biology and Medicine., 12, pp. 251-261.
133. Mansell P., Reckless, J. P. D., 1991, “Garlic: Effects on Serum Lipids, Blood
Pressure, Coagulation, Platelet Aggregation, and Vasodilation,” British Medical
Journal., 303, pp. 379-380.
134. Dausch, J. G., Nixon, D.W., 1990, “Garlic: A Review of its Relationship to
Malignant Disease,” Preventive Medicine., 19, pp. 346-361.
161
135. Hirsch, K., Danilenko, M., Giat, J., 2000, “Effect of Purified Allicin, the Major
Ingredient of Freshly Crushed Garlic, on Cancer Cell Proliferation,” Nutrition and
Cancer., 38, pp. 245-254.
136. Elkayam, A., Mirelman, D., Peleg, E., 2003, “The Effects of Allicin on Weight in
Fructose Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats,”
American Journal of Hypertension., 16, pp. 1053-1056.
137. Miron, T., Rabinkov, A., Peleg, E., Rosenthal, T., Mirelman, D., Wilchek, M.,
2004, “Allylmercaptocaptopril: A New Antihypertensive Drug,” American Journal
of Hypertension., 17, pp. 71-73.
138. Baroni, A., Buommino, E., Ruocco, E., Petrazzuolo, M., De Filippis, A., Satriano,
R. A., Ruocco, V., Cozza, V., Tufano, M. A., 2011, “Captopril Modulates
Acetylcholinesterase in Human Keratinocytes,” Archives of Dermatological
Research., Article in press.
139. Moulder, J. E., Cohen, E. P., Fish, B. L., 2011, “Captopril and Losartan for
Mitigation of Renal Injury Caused by Single-dose Total-body Irradiation,”
Radiation Research., 175, pp. 29-36.
140. Amirshahrokhi, K., Ghazi-Khansari, M., Mohammadi, A., Farani, K. G., 2010,
“Effect of Captopril on TNF-α and IL-10 in the Livers of Bile Duct Ligated Rats,”
Iranian Journal of Immunology., 7, pp. 247-251.
141. Li, S. L., Chen, X., Zhang, X. W., Wu, T., Ji, Z. Z., 2010, “Protective Effects of
Captopril Against Lung Injury In Rats With Severe Acute Pancreatitis,” Nan Fang
Yi Ke Da Xue Xue Bao., 30, pp. 2742-2745.
142. Saghaei, F., Karimi, I., Jouyban, A., Samini, M., 2010, “Effects of Captopril on the
Cysteamine-induced Duodenal Ulcer in the Rat,” Experimental and Toxicologic
Pathology., Article in press.
143. Asdaq, S. M., Inamdar, M. N., 2010, “Potential of Garlic and its Active
Constituent, S-Allyl Cysteine, as Antihypertensive and Cardioprotective in
Presence of Captopril,” Phytomedicine., 17, pp. 1016-1026.
144. Asdaq, S. M., Inamdar, M. N., 2010, “Pharmacodynamic Interaction of Captopril
with Garlic in Isoproterenol-induced Myocardial Damage in Rat,” Phytotherapy
Research., 24, pp. 720-725.
145. Miguel-Carrasco, J. L., Zambrano, S., Blanca, A. J., Mate, A., Vázquez, C. M.,
2010, “Captopril Reduces Cardiac Inflammatory Markers in Spontaneously
Hypertensive Rats by Inactivation of NF-kB,” Journal of Inflammation (London).,
12, pp. 21.
162
146. Roozbeh, J., Banihashemi, M. A., Ghezlou, M., Afshariani, R., Salari, S., Moini,
M., Sagheb, M. M., 2010, “Captopril and Combination Therapy of Captopril and
Pentoxifylline in Reducing Proteinuria in Diabetic Nephropathy,” Renal Failure.,
32, pp. 172-178.
147. Zdionchenko, V. S., Leksina, K. S., Timofeeva, N., Shekhian, G. G., Bagatyrova,
K. M., Mironova, M. A., 2009, “Effect of Angiotensin Converting Enzyme
Inhibitors on Oxidative Stress, Endothelial Function in Patients with Myocardial
Infarction,” Kardiologiia., 49, pp. 32-37.
148. Li, G. X., Liu, Z. Q., 2009, “Captopril and 6-mercaptopurine: Whose SH possess
Higher Antioxidant Ability?,” European Journal of Medicinal Chemistry., 44, pp.
4841-4847.
149. Toshio, O., Shigehiro, T., Yoshitomo, K., Shunichiro, K., 2008, “Protective Effect
of Captopril and Enaraprilat, Angiotensin-converting Enzyme Inhibitors, on Para-
nonylphenol-induced OH Generation and Dopamine Efflux in Rat Striatum,”
Toxicology., 250, pp. 96-99.
150. Miyazaki, A., Kitaichi, N., Ohgami, K., Iwata, D., Jin, X. H., 2008, “Anti-
inflammatory Effect of Angiotensin Type 1 Receptor Antagonist on Endotoxin-
induced Uveitis in Rats,” Graefes Archive for Clinical and Experimental
Ophthalmology., 246, pp. 747-757.
151. Bucci, M., Roviezzo, F., Brancaleone, V., Di Lorenzo, A., 2008, “ACE-inhibition
Ameliorates Vascular Reactivity and Delays Diabetes Outcome in NOD Mice,”
Vascular Pharmacology., 49, pp. 84-90.
152. Zhang, J. Z., Xi, X., Gao, L., Kern, T. S., 2007, “Captopril Inhibits Capillary
Degeneration in the Early Stages of Diabetic Retinopathy,” Current Eye research.,
32, pp. 883-889.
153. Ostergren J., 2007, “Renin Angiotensin System Blockade in the Prevention of
Diabetes,” Diabetes Research and Clinical Practice., 76S, pp. S13-S21.
154. Pasini, A. F., Garbin, U., Nava, M. C., Stranieri, C., 2007, “Effect of Sulfhydryl
and Non-sulfhydryl Angiotensin-converting Enzyme Inhibitors on Endothelial
Function in Essential Hypertensive Patients,” Americal Journal of Hypertension.,
20, pp. 443-450.
155. Ghazi-Khansari, M., Mohammadi-Bardbori A., 2007, “Captopril Ameliorates
Toxicity Induced by Paraquat in Mitochondria Isolated from the Rat Liver,”
Toxicolology In Vitro., 21, pp. 403-407.
163
156. Kalia, K., Narula, G. D., Kannan, G. M., Flora, S. J. S., 2007, “Effects of
Combined Administration of Captopril and DMSA on Arsenite Induced Oxidative
Stress and Blood and Tissue Arsenic Concentration in Rats,” Compound
Biochemistry and Physiology., 144, pp. 372-379.
157. Fiordaliso, F., Cuccovillo, I., Bianchi, R., Bai, A., 2006, “Cardiovascular
Oxidative Stress is Reduced by an ACE inhibitor in a Rat Model of
Streptozotocin-induced Diabetes,” Life Sciences., 79, pp. 121-129.
158. Rosenkranz, A. C., Heinrich, L., Thomas, B., Reinhard, B., Renate, R., 2006,
“Endothelial Antioxidant Actions Dihydropyridines and Angiotensin Converting
Enzyme Inhibitors,” European Journal of Pharmacology., 592, pp. 55-62.
159. Ilieva, I., Ohgami, K., Xue-Hai, J., Suzuki, Y., Shiratori, K., 2006, “Captopril
Suppresses Inflammation in Endotoxin-induced Uveitis in Rats,” Experimental
Eye Research., 83, pp. 651-657.
160. Mariee, A. D., Al-Shabanah, O., 2006, “Protective Ability and Binding Affinity of
Captopril Towards Serum Albumin in an in vitro Glycation Model of Diabetes
Mellitus,” Journal of Pharmaceutical and Biomedical Analysis., 41, pp. 571-575.
161. Basso, N., Paglia, N., Stella, I., Elena, M. V., De Cavanagh., 2005, “Protective
Effect of the Inhibition of the Renin Angiotensin System on Aging,” Regulatory
Peptides., 128, pp. 247-252.
162. Evangelista, S., Manzini, S., 2005, “Antioxidant and Cardioprotective Properties
of the Sulfhydryl Angiotensin Converting Enzyme Inhibitor Zofenopril,” The
Journal of International Medical Research., 33, pp. 42-54.
163. Leiter, L. A., Lewanczuk, R. Z., 2005, “Of the Rennin Angiotensin System and
Reactive Oxygen Species: Type 2 Diabetes and Angiotensin II Inhibition,”
American Journal of Hypertension., 18, pp. 121-128.
164. Jian-Ping, Z., Hong-Shan, W., Shun-Ai, L., Jing-Jing, G., Qian-Ying, Z., Xiao-
Hong, S., Si-Ping, Z., Zhi-Ying, L., Xin F., Hong-Buo, L., 2004, “Effect of
Enalapril on Acute Liver Injury Induced by CCl4 in Rats and its Anti-oxidative
Function,” World Chinese Journal of Digestology., 12, pp. 2638-2641.
165. Elena, M. V., De Cavanagh, E., Piotrkowski, B., Fraga, C. G., 2004. “Concerted
Action of the Rennin Angiotensin System, Mitochondria, and Antioxidant
Defenses in Aging,” Molecular Aspects of Medicine., 25, pp. 27-36.
166. Napoli, C., Sica, V., De Nigris, F., Pignalosa, O., Condorelli, M., 2004,
“Sulfhydryl Angiotensin Converting Enzyme Inhibition Induces Sustained
164
Reduction of Systemic Oxidative Stress and Improves the Nitric oxide Pathway in
Patients with Essential Hypertension,” American Heart Journal., 148, pp. K1-K7.
167. Yavuz, D., Kucukkaya, B., Haklarb, G., Ersoz, O., Akogluc, E., Akalin, S., 2003,
“Effects of Captopril and Losartan on Lipid Peroxidation, Protein Oxidation and
Nitric oxide Release in Diabetic Rat Kidney,” Prostaglandins, Leukotrienes and
Essential Fatty Acids., 69, pp. 223-227.
168. Zhang, J. Z., Gao, L., Widness, M., Xi, X., Kern, T. S., 2003, “Captopril Inhibits
Glucose Accumulation in Retinal Cells in Diabetes,” Investigative ophthalmology
and Visual Sciences., 44, pp. 4001-4005.
169. Scribner, A. W., Loscalzo, J., Napoli, C., 2003, “The Effect of Angiotensin
Converting Enzyme Inhibition on Endothelial Function and Oxidant Stress,”
European Journal of Pharmacology., 482, pp. 95-99.
170. Cominacini, L., Pasini, A. F., Garbin, U., Evangelista, S., 2002, “Zofenopril
Inhibits the Expression of Adhesion Molecules on Endothelial Cells by Reducing
Reactive Oxygen Species,” American Journal of Hypertention., 15, pp. 891-895.
171. Pradhan, R., Fong, D., March, C., Jack, R., 2002, “Angiotensin Converting
Enzyme Inhibition for the Treatment of Moderate to Severe Diabetic Retinopathy
in Normotensive Type 2 Diabetic Patients: A pilot study,” Journal of Diabetes
Complications., 16, pp. 377-381.
172. Thorpe, S. R., Alderson, N. L., Chachich, M. E., Januszweski, A., 2002, “Role of
Dyslipidemia and AGE/ALE Formation in the Progression of Nephropathy and
Retinopathy in STZ-diabetic Rats,” International Congress Series., 1245, pp. 169-
173.
173. EI-Khatib, A. S., Mansour, M. A., 2001, “Prior Treatment with Captopril
Attenuates Carbon tetrachloride Induced Liver Injury in Mice,” Research
Communication in Molecular Pathology and Pharmacolology., 110, pp. 3-16.
174. De Nigris, F., D‟Armiento, F. P., Somma, P., 2001, “Chronic Treatment with
Sulfhydryl Angiotensin Converting Enzyme Inhibitors Inhibit Susceptibility of
LDL to in vitro Oxidation, Formation of Oxidation Specific Epitopes in the
Arterial Wall, and Atherogenesis in Apolipoprotein E Knockout Mice,”
International Journal of Cardiology., 81, pp. 107-115.
175. Sacco, G., Bigioni, M., Evangelista, S., Goso, C., Manzini, S., Maggi, C. A., 2001,
“Cardioprotective Effects of Zofenopril, A New Angiotensin Converting Enzyme
Inhibitor, on Doxorubicin-induced Cardiotoxicity in the Rat,” European Journal of
Pharmacology., 414, pp. 71-78.
165
176. Azza, A. M., Mansour, M., 2000, “Effects of Captopril on Interleukin-6,
Leukotriene B4, and Oxidative Stress Markers in Serum and Inflammatory
Exudates of Arthritic Rats: Evidence of Anti-inflammatory Activity,”
Toxicolology and Pharmacology., 168, pp. 123-130.
177. Ravati, A., Junker, V., Kouklei, M., Ahlemeyer, B., 1999, “Enalapril and
Moexipril Protect from Free Radical-induced Neuronal Damage in vitro and
Reduce Ischemic Brain Injury in Mice and Rats,” European Journal of
Pharmacology., 373, pp. 21-33.
178. Napoli, C., Cicala, C., D‟Armiento, F. P., 1999, “Beneficial Effects of ACE
Inhibition with Zofenopril on Plaque Formation and Low-density Lipoprotein
Oxidation in Watanabe Heritable Hyperlipidemic Rabbits,” General
Pharmacology., 33, pp. 467-477.
179. Desideri, G., Bellini, C., Bmvi, M. C., Ginliani, E., Santuccl, A., Ferii, C., 1999,
“Comparative Study on Zofenopril, Lisinopril, Enalapril and Captopril Effects on
Endothelin-1 and Nitric oxide Production,” Americal Journal of Hypertension., 12,
pp. D007.
180. Elena, M. V., De Cavanagh, E., Ferder, L., Carrasquedo, F., Scrivo, D., 1999,
“Higher Levels of Antioxidant Defenses in Enalapril-treated versus Non-
Enalapril-treated Hemodialysis Patients,” Americal Journal of Kidney Diseases.,
34, pp. 445-455.
181. Neal, R., Cooper, K., Kellogg, G., Gurer, H., Ercal, N., 1999, “Effects of Some
Sulfur-containing Antioxidants on Lead-exposed Lenses,” Free Radical Biology
and Medicine., 26, pp. 239-243.
182. Benzie, F., Tomlinson B., 1998, “Antioxidant Power of ACE Inhibitor in vitro,”
British Journal of Clinical Pharmacology., 45, pp. 168-169.
183. Chaturvedi, N., Sjolie, A., Stephenson, J. M., Abrahamian, H., Keipes, M., 1998,
“Effect of Lisinopril on Progression of Retinopathy in Normotensive People with
Type 1 Diabetes,” Lancet., 351, pp. 28-31.
184. Bartosz, M., Kedziora, J., Bartosz, G., 1997, “Antioxidant and Prooxidant
Properties of Captopril and Enalapril,” Free Radical Biology and Medicine., 23,
pp. 729-735.
185. Ottlecz, A., Bensaoula, T., 1996, “Captopril Ameliorates the Decreased Na+,K
+-
ATPase Activity in the Retina of Streptozotocin-induced Diabetic Rats,”
Investigative Ophthalmology and Visual Sciences., 37, pp. 1633-1641.
166
186. Elena, M. V., De Cavanagh, E., Inserra, F., Ferder, L., Romano, L., 1995,
“Superoxide Dismutase and Glutathione Peroxidase Activities are Increased by
Enalapril and Captopril in Mouse Liver,” FEBS Letters., 361, pp. 22-24.
187. Jan Danser, A. H., Derkx, F. H. M., Admiraal, P. J. J., Deinum, J., 1994,
“Angiotensin Levels in the Eye,” Investigative Ophthalmology and Visual
Sciences., 35, pp. 1008-1018.
188. Andreoli, S. P., 1993, “Captopril Scavenges Hydrogen Peroxide and Reduces but
does not Eliminate, Oxidant-induced Cell Injury,” American Journal of
Physiology. Renal Physiolology., 264, pp. 120-127.
189. Al-Harbi, M. M., 1993, “Effect of Captopril on the Cytological and Biochemical
Changes Induced by Adriamycin,” Food Chemistry and Toxicology., 31, pp. 209-
212.
190. Mak, I. T., Freedman, A. M., Dickens, B. F., Weglicki, W. B., 1990, “Protective
Effects of Sulfhydryl-containing Angiotensin Converting Enzyme Inhibitors
Against Free Radical Injury in Endothelial Cells,” Biochemical Pharmacology.,
40, pp. 2169-2175.
191. Xiu-jun, P., Xiu Chen, J., 1989, “Captopril and Ramiprilat Protect Against Free
Radical Injury in Isolated Working Rat Hearts,” Journal of Molecular Cell
Cardiology., 21, pp. 1261-1271.
192. Li, W., Wang, D., Song, G., Zuo, C., Qiao, X., Qin, S., 2010, “The Effect of
Combination Therapy of Allicin and Fenofibrate on High Fat Diet-induced
Vascular Endothelium Dysfunction and Liver Damage in Rats,” Lipids Health
Disease., 14, pp. 131.
193. Kelsey, N. A., Wilkins, H. M., Linseman, D. A., 2010, “Nutraceutical
Antioxidants as Novel Neuroprotective Agents,” Molecules., 15, pp. 7792-7814.
194. Shahsavani, D., Baghshani, H., Alishahi, E., 2010, “Efficacy of Allicin in
Decreasing Lead (Pb) Accumulation in Selected Tissues of Lead-Exposed
Common Carp (Cyprinus carpio),” Biological Trace Element Research., 2010,
Article in press.
195. Siddique, Y. H., Beg, T., Ara, G., Gupta, J., Afzal, M., 2010, “Antigenotoxic
Effect of Allicin Against Estradiol-17beta-induced Genotoxic Damage in Cultured
Mammalian Cells,” Natural Product Research., 24, pp. 1087-1094.
196. Arzanlou, M., Bohlooli, S., 2010, “Inhibition of Streptolysin O by Allicin: An
Active Component of Garlic,” Journal of Medical Microbiology., 59, pp. 1044-
1049.
167
197. Vazquez-Prieto, M. A., Gonzalez, R. E., Renna, N. F., Galmarini, C. R., Miatello,
R. M., 2010, “Aqueous Garlic Extracts Prevent Oxidative Stress and Vascular
Remodeling in an Experimental Model of Metabolic Syndrome,” Journal of
Agricultural Food Chemistry., 58, pp. 6630-6635.
198. Liu, C., Cao, F., Tang, Q. Z., Yan, L., Dong, Y. G., Zhu, L. H., Wang, L., Bian, Z.
Y., Li, H., 2010, “Allicin Protects Against Cardiac Hypertrophy and Fibrosis via
Attenuating Reactive Oxygen Species-dependent Signaling Pathways,” Journal of
Nutrition and Biochemistry., 21, pp. 1238-1250.
199. Miron, T., Listowsky, I., Wilchek, M., 2010, “Reaction Mechanisms of Allicin and
Allyl-mixed Disulfides with Proteins and Small Thiol Molecules,” European
Journal of Medicinal Chemistry., 45, pp. 1912-1918.
200. Wang, L., Song, M., Hang, T. J., Zhang, Z. X., Shen, W. B., Song, Z., Chen, J.,
2009, “Metabonomic Study on the Effects of Allicin on Rats,” Yao Xue Xue Bao.,
44, pp. 1019-1024.
201. Aslani, M. R., Najarnezhad, V., Mohri, M., 2010, “Individual and Combined
Effect of Meso-2,3-dimercaptosuccinic acid and Allicin on Blood and Tissue Lead
Content in Mice,” Planta Medica., 76, pp. 241-244.
202. Horev-Azaria, L., Eliav, S., Izigov, N., Pri-Chen, S., Mirelman, D., Miron, T.,
Rabinkov, A., Wilchek, M., Jacob-Hirsch, J., Amariglio, N., Savion, N., 2009,
“Allicin Up-regulates Cellular Glutathione Level in Vascular Endothelial Cells,”
European Journal of Nutrition., 48, pp. 67-74.
203. Hoskinson, J., Shelat, K., 2009, “The Effect of Allicin on Escharichia coli,”
California State Science Fair, Project Summary 2009.
204. Anoush, M., Eghbal, M. A., Fathiazad, F., Hamzeiy, H., Kouzehkonani, N. S.,
2009, “The Protective Effects of Garlic Extract Against Acetaminophen-induced
Oxidative Stress and Glutathione Depletion,” Pakistan Journal of Biological
Science., 12, pp. 765-771.
205. Najar, N., Aslani, M. R., Balali, M., 2008, “Evaluation of Allicin for the Treatment
of Experimentally Induced Subacute Lead Poisoning in Sheep,” Biological Trace
Elemental Research., 126, pp. 141-147.
206. Fujisawa, H., Suma, K., Origuchi, K., Seki, T., Ariga, T., 2008, “Thermostability
of Allicin Determined by Chemical and Biological Assays,” Bioscience,
Biotechnology and Biochemistry., 72, pp. 2877-2883.
207. Zhang, Y., Yao, H. P., Huang, F. F., Wu, W., Gao, Y., Chen, Z. B., Liang, Z. Y.,
Liang, T. B., 2008, “Allicin, A Major Component of Garlic, Inhibits Apoptosis in
168
Vital Organs in Rats with Trauma or Hemorrhagic Shock,” Critical Care
Medicine., 36, pp. 3226-3232.
208. Su, Q. S., Tian, Y., Zhang, J. G., Zhang, H., 2008, “Effects of Allicin
Supplementation on Plasma Markers of Exercise-induced Muscle Damage, IL-6
and Antioxidant Capacity,” European Journal of Applied Physiology., 103, pp.
275-283.
209. Mahmoud, H. S., Mahmoud, S. S., Baluchnejadmojarad, T., 2007, “Garlic Extract
Reduces Serum Angiotensin Converting Enzyme Activity in Nondiabetic and
Streptozocin Diabetic Rats,” Pathophysiology., 14, pp. 109-112.
210. Antosiewicz, H., Powolyny, A., Singh, S. V., 2007, “Molecular Targets of Cancer
Chemoprevention by Garlic-derived Organosulfides,” Acta Pharmacologica
Sinica., 28, pp. 1355-1364.
211. Takasu, J., Uykimpang, R., Alenor, S. M., Amagase, H., 2006, “Significance of
Garlic and its Constituents in Cancer and Cardiovascular Diseases- Aged Garlic is
a Potential Therapy for Sickle Cell Anemia,” Journal of Nutrition., 136, pp. 803S-
805S.
212. Seong, J. C., Dong, K. R., Suhkneung, P., 2006, “Allicin, A Major Component of
Garlic, Inhibits Apoptosis of Macrophage in a Depleted Nutritional State,” Basic
Nutrition Investigation., 22, pp. 1177-1184.
213. Raymond, B., Siess, M. H., Arnault, I., Jacques, A., Marie France, P., Marie
France, V., 2004, “Comparision of the Chemopreventive Efficacies of Garlic
Preparations with Different Allicin Contents Against Aflatoxin B1
Carcinogenecity in Rats,” Carcinogenesis., 25, pp. 1953-1959.
214. Amitai, E., Mirelman, D., Peleg, E., Wilchek, M., Miron, T., Rabinkov, A.,
Moron, H., Rosenthal, T., 2003, “The Effects of Allicin on Weight in Fructose-
induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats.,” American
Journal of Hypertension., 16, pp. 1053-1056.
215. Rahman, K., 2003, “Garlic and Aging: New Insights into an Old Remedy,” Aging
Research Review., 2, pp. 39-56.
216. Cruz, G., 2001, “Synthesis of Allicin and Purification by Solid-Phase Extraction,”
Analytical Biochemistry., 290, pp. 376-378.
217. Miron, T., Rabinkov, A., Mirelman, D., Wilchek, M., Weiner, L., 2000, “The
Mode of Action of Allicin: Its Ready Permeability Through Phospholipid
Membranes may Contribute to its Biological Activity,” Biochemica Biophysica
Acta., 1463, pp. 20-30.
169
218. Yoshida, H., Katsuzaki, H., Ohta, R., Ishikawa, K., Fukuda, H., Fujini, T., Suzuki,
A., 1999, “Antimicrobial Activity of the Thiosulfinates Isolated from Oil-
macerated Garlic Extract,” Basic Biotechnology and Biochemistry., 63, pp. 591-
594.
219. Siegers, C. P., Steffen, B., Robke, A., Pentz, R., 1999, “The Effects of Garlic
Preparations Against Human Tumor Cell Proliferation,” Phytomedicine., 6, pp. 7-
11.
220. Siegers, C. P., Robke, A., Pentz, R., 1999, “Effects of Garlic Preparations on
Superoxide Production by Phorbol Ester Activated Granulocytes,” Phytomedine.,
6, pp. 6-13.
221. Dirsch, V. M., Kiemer, A. K., Wagner, H., Vollmar, A. M., 1998, “Effect of
Allicin and Ajoene, Two Compounds of Garlic, on Inducible Nitric oxide
Synthase,” Atherosclerosis., 139, pp. 333–339.
222. Rabinkov, A., Miron, T., Konstantinovski, L., Wilchek, M., Mirelman, D., Weiner,
L., 1998, “The Mode of Action of Allicin: Trapping of Radicals and Interaction
with Thiol-containing Proteins,” Biochimica et Biophysica Acta., 1379, pp. 233-
244.
223. Ankri, S., Miron, T., Rabinkov, A., Wilchek, M., Mirelman, D., 1997, “Allicin
from Garlic Strongly Inhibits Cysteine Proteinases and Cytopathic Effects of
Entamoeba histolytica,” Antimicrobial Agents and Chemotherapy., 41, pp. 2286-
2288.
224. Gebhardt, R., Beck, H., 1996, “Differential Inhibitory Effects of Garlic Derived
Organosulfur Compounds on Cholesterol Biosynthesis in Primary Rat Hepatocyte
Cultures,” Lipids., 31, pp. 1269-1276.
225. Mikhin, V. P., Gromnatskii, N. I., 1996, “The Effect of Garlic Preparation on the
Level of Lipid Peroxidation Products, Activity of Various Antioxidant Enzymes,
and Blood Level of Lipoproteins in Patients with Atheroscelrosis,” Biulletene
Eskeperimental Noi Biologii Medistiny., 122, pp. 502-504.
226. Jaiswal, S. K., Bordia, A., 1996, “Radioprotective Effect of Garlic (Allium
sativum, Linn.) in albino rats,” Indian Journal of Medical Sciences., 50, pp. 231-
233.
227. Chu, T. C., Ogidiben, M., Han, J. C., Potter, D. E., 1993, “Allicin-induced
Hypotension in Rabbits,” Journal of Ocular Pharmacology., 9, pp. 201-109.
228. Zhang, R. S., 1992, “A Clinical Study on Allicin in the Prevention of Thrush in
Newborn Infants,” Zhongguo Zhong Xi Yi Jie He Za Zhi., 12, pp. 28-29.
170
229. Gebhardt, R., 1991, “Inhibition of Cholesterol Biosynthesis by a Water-soluble
Garlic Extract in Primary Cultures of Rat Hepatocytes,” Arzneimittelforschung.,
41, pp. 800-804.
230. Focke, M., Feld, A., Lichtenthaler, K., 1990, “Allicin, A Naturally Occurring
Antibiotic from Garlic, Specifically Inhibits Acetyl-CoA Synthetase,” FEBS
Letters., 261, pp. 106-108.
231. Shalinsky, D. R., McNamara, D. B., Agrawal, K. C., 1989, “Inhibition of GSH-
dependent PGH2 Isomerase in Mammary Adenocarcinoma Cells by Allicin,”
Prostaglandins., 37, pp. 135-148.
232. Knasmuller, S., de Martin, R., Domjan, G., Szakmary, A., 1989, “Studies on the
Antimutagenic Activities of Garlic Extract,” Environmental Molecule Mutagen.,
13, pp. 357-365.
233. Mayeux, P. R., Agarwal, J., Tou, H., King, B. T., Lippton, H. L., Hyman, A. L.,
1988, “The Pharmacological Effects of Allicin, A Constituent of Garlic Oil,”
Agents and Actions., 25, pp. 182-190.
234. Younis F., Mirelman, D., Rabinkov, A., Rosenthal, T., 2010, “S-
allylmercaptocaptopril: A Novel Compound in the Treatment of Cohen-Rosenthal
Diabetic Hypertensive Rats,” Journal of Clinical Hypertension (Greenwich)., 12,
pp. 451-455.
235. Ernsberger, P., Janean, L., Rosenthal, T., Mirelman, D., Richard, J. K., 2007,
“Therapeutic Actions of Allylmercaptocaptopril and Captopril in a Rat Model of
Metabolic Syndrome,” American Journal of Hypertension., 20, pp. 866-874.
236. Oron-Herman, M., Rosenthal, T., Mirelman, D., Miron, T., Rabinkov, A.,
Wilchek, M., 2005, “The Effect of S-allylmercaptocaptopril, the Synthetic Product
of Allicin and Captopril, on Cardiovascular Risk Factors Associated with the
Metabolic Syndrome,” Atherosclerosis., 183, pp. 238-243.
237. Devamanoharan, P. S., Henein, M., Ali, A. H., Varma, S. D., 1999, “Attenuation
of Sugar Cataract by Ethyl pyruvate,” Moleclar Cell Biochemistry., 200, pp. 103-
109.
238. Yagci, R., Aydin, B., Erdurmus, M., Karadag, R., Gurel, A., Durmus, M., 2006,
“Use of Melatonin to Prevent Selenite-induced Cataract Formation in Rat Eyes,”
Current Eye Research., 31, pp. 845-850.
239. Shearer, T. R., Ma, H., Fukiage, C., Azuma, M., 1997, “Selenite Nuclear Cataract:
Review of the Model,” Molecular Vision., 3, pp. 8.
171
240. HOPE Investigators., 2000, “Effects of Ramipril on Cardiovascular and
Microvascular Outcomes in People with Diabetes Mellitus: Results of the HOPE
Study and MicroHOPE Substudy,” Lancet., 355, pp. 253-259.
241. Parving, H. H., Lehnert, H., Brochner-Mortensen, J., Gomis, R., Andersen, S.,
Arner, P., 2001, “Irbersartan in Patients with Type 2 Diabetes and
Microalbuminuria Study Group, The Effect or Irbersartan on the Development of
Diabetic Nephropathy in Patients with Type 2 Diabetes,” National England
Journal of Medicine., 345, pp. 870-878.
242. Park, J. B., Intengan, H. D., Schiffrin, E. L., 2000, “Reduction of Resistance
Artery Stiffness by Treatment with the AT1-receptor Antagonist Losartan in
Essential Hypertension,” Journal of Renin Angiotensin Aldosterons System., 1,
pp. 40-45.
243. De Cavanagh, E., Inserra, F., Ferder, L., Fraga, C., 2000, “Enalapril and Captopril
Enhance Glutathione-dependent Antioxidant Defenses in Mouse Tissues,”
American Journal of Physiology., 278, pp. R572-R577.
244. Kukreja, R. C., Kontos, H. A., Hess, M. L., 1990, “Captopril and Enalaprilat do
not Scavenge the Superoxide Anion,” American Journal of Cardiology., 65, pp.
24I-27I.
245. Mira, M. L., Silva, M. M., Queiroz, M. J., Manso, C. F., 1993, “Angiotensin
Converting Enzyme Inhibitors as Oxygen Free Radical Scavengers,” Free Radical
Research Communication., 19, pp. 173-181.
246. Chopra, M., Beswick, H., Clapperton, M., Dargie, H. J, Smith, W.E., McMurray,
J., 1992, “Antioxidant Effects of Angiotensin Converting Enzyme (ACE)
Inhibitors: Free Radical and Oxidant Scavenging are Sulfhydryl Dependent, but
Lipid Peroxidation is Inhibited by both Sulfhydryl- and Nonsulfhydryl Containing
ACE Inhibitors,” Cardiovascular Pharmacology., 19, pp. 330-340.
247. Ghazi-Khansari, M., Nasiri, G., Honarjoo, M., 2005, “Decreasing the Oxidant
Stress from Paraquat in Isolated Perfused Rat Lung Using Captopril and Niacin,”
Archives of Toxicology., 79, pp. 341-345.
248. Ostadalova, I., Babicky, A., Obenberger, J., 1978, “Cataract Induced by
Administration of a Single Dose of Sodium Selenite to Suckling Rats,”
Experientia., 34, pp. 222-223.
249. Ghazi-Khansari, M., Mohammadi-Bardbori, A., 2007, “Non-thiol ACE Inhibitors,
Enalapril and Lisinopril are Unable to Protect Mitochondrial Toxicity due to
Paraquat,” Pesticide Biochemistry Physiology., 89, pp. 163-167.
172
250. Moron, M. S., Depierre, J. W., Mannervik, B., 1979, “Levels of Glutathione,
Glutathione Reductase and Glutathione S-transferase Activities in Rat Lung and
Liver,” Biochimica et Biophysica Acta., 82, pp. 67.
251. Ohkawa, H., Ohishi, N., Yagi, K., 1979, “Assay of Lipid Peroxide in Animal
Tissue by Thiobarbituric Acid Reaction,” Analytical Biochemistry., 95, pp. 351.
252. Lowry, O. H., Rosebrough, N. J., Farr, A. I., 1951, “Protein Measurement with the
Folin Phenol Reagent,” Journal of Biological Chemistry., 193, pp. 265.
253. Shearer, T. R., Anderson, R. S., Britton, J. L., Palmer, E. A., 1983, “Early
Development of Selenium-induced Cataract: Slit Lamp Evaluation,” Experimental
Eye Research., 36, pp. 781-788.
254. Chylack, L. T., Kinashita, J. H., 1969, “A Biochemical Evaluation of a Cataract
Induced in a High Glucose Medium,” Investigative Ophthalmology., 8, pp. 401-
412.
255. Shinohara, T., Piatigorsky, J., 1977, “Regulation of Protein Synthesis, Intracellular
Electrolytes and Cataract Formation in vitro,” Nature., 270, pp. 406-411.
256. Noda, Y., Mori, A., Packer, L., 1997, “Free Radical Scavenging Properties of
Alacepril Metabolites and Lisinopril,” Research Communications in Molecular
Pathology and Pharmacology., 96, pp. 125-136.
257. Al-Shabanad, O., Mansour, M., El-Khasef, H., Al-Bekairi, A., 1998, “Captopril
Ameliorates Myocardial and Haematological Toxicities Induced by Adriamycin,”
Biochemistry and Molecular Biology International., 45, pp. 419-427.
258. Aruoma, O., Akanumu, D., Cecchini, R., Hariwell, B., 1991, “Evaluation of the
Ability of the Angiotensin Converting Enzyme Inhibitor Captopril to Scavenge
Reactive Oxygen Species,” Chemico-biological Interactions., 77, pp. 303-314.
259. Bartosz, M., Kedziora, J., Bartosz, G., “Antioxidant and Pro-oxidant Properties of
Captopril and Enalapril,” Free Radical Biology and Medicine., 23, pp. 29-35.
260. Benzie, I., Tomlison, B., 1998, “Antioxidant Power of Angiotensin Converting
Enzyme Inhibitors in vitro,” British Journal of Clinical Pharmacology., 45, pp.
168-169.
261. Gillis, C. N., Chen, X., Merker, M. M. 1992, “Lisinopril and Ramiprilat Protection
of the Vascular Endothelium Against Free Radical-induced Functional Injury,”
Journal of Pharmacology and Experimental Therapeutics., 262, pp. 212-216.
173
262. Hayek, T., Attias, J., Breslow, J. L., Keidar, S., 1998, “Antiatherosclerotic and
Antioxidative Effects of Captopril in Apolipoprotein-E-deficient Mice,” Journal of
Cardiovascular Pharmacology., 31, pp. 540-544.
263. Ruiz-Munoz, L. M., Vidal-Vanaclocha, F., Lampreabe, I., 1997, “Enalaprilat
Inhibits Hydrogen Peroxide Production by Murine Mesangial Cells Exposed to
High Glucose Concentrations,” Nephrology, Dialysis, Transplantation., 12, pp.
456-464.
264. Elena, M. V., De Cavanagh E. M., Inserra, F., Ferder, L., Fraga, C. G., 2000,
“Enalapril and Captopril Enhance Glutathione-dependent Antioxidant Defenses in
Mouse Tissues,” American Journal of Physiology. Regulatory, Integrative and
Comparative Physiology., 278, pp. 572-577.
265. Rorive, G., Kleinzeller, A., 1974, “Ca2+
-activated ATPase from Renal Tubular
Cells,” Methods of Enzymology., 1974; 32, pp. 303-306.
266. Mishra, H. P., Fridovich, I., 1976, “The Oxidation of Phenylhydrazine: Superoxide
and Mechanism,” Biochemistry., 15, pp. 681-687.
267. Aebi, H., 1974, “Catalase” In: Bergmeyer, H. E., editors. “Methods of Enzymatic
Analysis,” Vol 2, 1st edition, Academic Press, London, pp. 673-677.
268. Paglia, D. E., Valentine, W. N., 1967, “Studies on the Quantitative and Qualitative
Characterization of Erythrocyte Glutathione Peroxidase,” Journal of Laboratory
and Clinical Medicine., 70, pp. 158-159.
269. Hebig, H., 1974, “Gultathione S-tranferase, The First Enzymatic Step in
Mercapturic Acid Formation,” Journal of Biochemistry., 249, pp. 7130-7134.
270. Wride, M. A., 1996, “Cellular and Molecular Features of Lens Differentiation: A
Review of Recent Advances,” Differentiation., 61, pp. 77-93.
271. Galvan, A., Louis, C. F., 1988, “Calcium Regulation by Lens Plasma Membrane
Vesicles,” Archives of Biochemistry and Biophysics., 264, pp. 472-481.
272. Gupta, P. D., Johar, K., Vasavada, A., 2004, “Causative and Preventive Action of
Calcium in Cataractogenesis,” Acta Pharmacologica Sinica., 25, pp. 1250-1256.
273. Liu, L., Paterson, C. A., Borchman, D., 2002, “Regulation of Sarco/endoplasmic
Ca2+
-ATPase Expression by Calcium in Human Lens Cells,” Experimental Eye
Research., 75, pp. 583-590.
174
274. McCord, J. M., Fridovich, I., 1969, “Superoxide Dismutase. An Enzymatic
Function for Erythrocuprein (Hemocuprein),” Journal of Biological Chemistry.,
244, pp. 6049-6055.
275. Varma, S., Ets, T., Richards, R. D., 1977. “Protection Against Superoxide Radicals
in Rat Lens,” Ophthalmic Research., 9, pp. 421-431.
276. Pirie, A., 1965, “Glutathione Peroxidase in Lens and a Source of Hydrogen
Peroxide in Aqueous Humour,” Biochemistry Journal., 96, pp. 244-253.
277. Russell, P., Yamada, T., Xu, G. T., Garland, D., Zigler, J. S., 1991, “Effects of
Naphthalene Metabolites on Cultured Cells from Eye Lens,” Free Radical
Biology and Medicine., 10, pp. 255-261.
278. Bhuyan, K. C., Bhuyan, D. K., 1970, “Catalase in Ocular Tissue and its
Intracellular Distribution in Corneal Epithelium,” American Journal of
Ophthalmology., 69, pp. 147-153.
279. Santini, S. A., Marra, G., Giardina, B., Cotroneo, P., Manto, A., Ghirlanda, A.,
1997, “Defective Plasma Antioxidant Defenses and Enhanced Susceptibility to
Lipid Peroxidation in Uncomplicated IDDM,” Diabetes., 46, pp. 1853-1858.
280. Torok, B., Belagyi, J., Rietz, B. R., 1994, “Effectiveness of Garlic on the Radical
Activity in Radical Generating Systems,” Arzneimittelforschung., 44, pp. 608-611.
281. Stoll, A., Seebeck, E., 1948, “Die Synthese Des Naturlichen Alliins und Seiner
Drei Optisch Aktiven Isomerasen,” Helvetica Chimica Acta., 31, pp. 189-210.
282. Elkayam, A., Mirelman, D., Peleg, E., 2001, “The Effect of Allicin and Enalapril
in Fructose Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats,”
Journal of Hypertension., 14, pp. 377-381.
283. Ali, M., Al-Qattan, K., Al-Enzi, F., 2000, “Effects of Allicin from Garlic Powder
on Serum Lipids and Blood Pressure in Rats Fed with High Cholesterol Diet,”
Prostaglandins, Leukotrienes and Essential Fatty Acids., 64, pp. 253-259.
284. Efendy, J. L., Simmons, D. L., Campbell, G. R., 1997, “The Effect of the Aged
Garlic Extract, “Kiolic”, On the Development of Experimental Atherosclerosis,”
Atherosclerosis., 132, pp. 37-42.
285. Lawson, L. D., Hughes, B. G., 1992, “Inhibition of Whole Platelet Aggregation by
Compounds in Garlic Clove Extracts and Commercial Products,” Thrombosis
Research., 65, pp. 141-156.
175
286. Taylor, A., Hobbs, M., 2001, “2001 Assessment of Nutritional Influences on Risk
of Cataract,” Nutrition., 17, pp. 845-857.
287. Berlett, B. S., Stadtman, E. R., 1997, “Protein Oxidation in Aging, Disease, and
Oxidative Stress,” Journal of Biological Chemistry., 272, pp. 20313-20316.
288. Donma, O., Yorulmaz, E., Pekel, H., Suyugul, N., 2002, “Blood and Lens Lipid
Peroxidation and Antioxidant Status in Normal Individuals, Senile and Diabetic
Cataractous Patients,” Current Eye Research., 25, pp. 9-16.
289. Ozmen, B., Ozmen, D., Erkin, E., Guner, I., Habif, S., Bayindir, O., 2002, “Lens
Superoxide Dismutase and Catalase Activities in Diabetic Cataract,” Clinical
Biochemistry., 35, pp. 69-82.
290. Ates, N. A., Yildirim, O., Tamer, L., Unlu, A., Ercan, B., Muslu, N., 2004,
“Plasma Catalase Activity and Malondialdehyde Level in Patients with Cataract,”
Eye., 18, pp. 785-788.
291. Hashim, Z., Zarina, S., 2006, “Antioxidant Markers in Human Senile and Diabetic
Cataractous Lenses,” Journal of the College of Physicians and Surgeons Pakistan.,
16, pp. 637-640.
292. Canales, A., Sanchez-Muniz, F. J., 2003, “Paraoxonase, Something More than an
Enzyme,” Medicina Clinica., 121, pp. 537-548.
293. Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., La
Du, B. N., 1998, “Paraoxonase Inhibits High-density Lipoprotein Oxidation and
Preserves its Functions: A Possible Peroxidative Role for Paraoxonase,” Journal of
Clinical Investigation., 101, pp. 1581-1590.
294. Watson, A. D., Berliner, J. A., Hama, S. Y., 1995, “Protective Effect of High
Density Lipoprotein Associated Paraoxonase: Inhibition of the Biological Activity
of Minimally Oxidized Low Density Lipoprotein,” Journal of Clinical
Investigation., 96, pp. 2882-2891.
295. Aviram, M., Rosenblatt, M., Billecke, S., 1999, “Human Serum Paraoxonase
(PON1) is Inactivated by Oxidized Low Density Lipoprotein and Preserved by
Antioxidants,” Free Radical Biology and Medicine., 26, pp. 892-904.
296. Jakubowski, H., 2000, “Calcium-dependent Human Serum Homocysteine
Thiolactone Hydrolase: A Protective Mechanism Against Protein N-
Homocysteinylation,” Journal of Biological Chemistry., 275, pp. 3957-3962.
176
297. Josse, D., Lockridge, O., Xie, W., Bartels, C. F., Schopfer, L. M., Masson, P.,
2001, “The Active Site of Human Paraoxonase (PON1),” Journal of Applied
Toxicology., 21, pp. S7-S11.
298. McElveen, J., Mackness, M. I., Colley, C. M., Peard, T., Warner, S., Walker C. H.,
1986, “Distribution of Paraoxon Hydrolytic Activity in the Serum of Patients After
Myocardial Infarction,” Clinical Chemistry., 32, pp. 671-673.
299. Navab, M., Hama-Levy, S., Van-Lenten, B. J., Fonarow, G. C., Cardinez, C. J.,
Castellani, L. W., 1997, “Mildly Oxidized LDL Induces an Increased
Apolipoprotein J/Paraoxonase Ratio,” Journal of Clinical Investigation., 99, pp.
2005-2019.
300. Abbott, C. A., Mackness, M. I., Kumar, S., Boulton, A. J., Durrington, P. N., 1995,
“Serum Paraoxonase Activity, Concentration and Phenotype Distribution in
Diabetes Mellitus and its Relationship to Serum Lipids and Lipoproteins,”
Arteriosclerosis, Thrombosis and Vascular Biology., 15, pp. 1812-1818.
301. Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., Julier, K., Abuasha, B.,
1998. “Serum Paraoxonase (PON1) 55 and 192 Polymorphism and Paraoxonase
Activity and Concentration in Non-insulin Dependent Diabetes Mellitus,”
Atherosclerosis., 139, pp. 341-349.
302. Sakai, T., Matsuura, B., Onji, M., 1998, “Serum Paraoxonase Activity and
Genotype Distribution in Japanese Patients with Diabetes Mellitus,” Internal
Medicine., 37, pp. 581-584.
303. Dantoine, T. F., Debord, J., Charmes, J. P., Merle, L., Marquet, P., Lachatre, G.,
1998, “Decrease of Serum Paraoxonase Activity in Chronic Renal Failure,”
Journal of the American Society of Nephrology., 9, pp. 2082-2088.
304. Baskol, G., Demir, H., Baskol, M., Kilic, E., Ates, F., Kocer, D., 2005,
”Assessment of Paraoxonase 1 Activity and Malondialdehyde Levels in Patients
with Rheumatoid Arthritis,” Clinical Biochemistry., 38, pp. 951-955.
305. Raiszadeh, F., Solati, M., Etemadi, A., Azizi, F., 2004, “Serum Paraoxonase
Activity Before and After Treatment of Thyrotoxicosis,” Clinical Endocrinology.,
60, pp. 75-80.
306. Baskol, G., Karakucuk, S., Oner, A. O., Baskol, M., Kocer, D., Mirza, E., 2006,
“Serum Paraoxonase 1 Activity and Lipid Peroxidation Levels in Patients with
Age-related Macular Degeneration,” Ophthalmologica., 220, pp. 12-16.
177
307. Hashim, Z., Zarina, S., 2007, “Assessment of Paraoxonase Activity and Lipid
Peroxidation Levels in Diabetic and Senile Subjects Suffering from Cataract,”
Clinical Biochemistry., 40, pp. 705-709.
308. Erel, O., 2005, “A New Automated Colorimetric Method for Measuring Total
Oxidant Status,” Clinical Biochemistry., 38, pp. 1103-1111.
309. Erel, O., 2004, “A New Automated Method to Measure Total Antioxidant
Response Against Potent Free Radical Reactions,” Clinical Biochemistry., 37, pp.
112-119.
310. Kosecik, M., Erel, O., Sevinc, E., Selek, S., 2005, “Increased Oxidative Stress in
Children Exposed to Passive Smoking,” International Journal of Cardiology., 100,
pp. 61-64.
311. Gan, K. N., Smolen, A., Eckerson, H. W., La Du, B. N., 1991, ”Purification of
Human Serum Paraoxonase/Arylesterase,” Drug Metabolism and Disposition., 19,
pp. 100-106.
312. Halliwel, B., 2001, “Role of Free Radicals in the Neurodegenerative Diseases:
Therapeutic Implications for Antioxidant Treatment,” Drugs Aging., 18, pp. 685-
716.
313. Vinson, J. A., 2006, “Oxidative Stress in Cataracts,” Pathophysiology., 13, pp.
151-162.
314. Berlett, B. S., Stadtman, E. R., 1997, “Protein Oxidation in Aging, Disease, and
Oxidative Stress,” Journal of Biological Chemistry., 272, pp. 20313-20316.
315. Kregel, K. C., Zhang, H. J., 2007, “An Integrated View of Oxidative Stress in
Aging: Basic Mechanisms, Functional Effects and Pathological Considerations,”
American Journal of Physiology. Regulatory, Integrative and Comparative
Physiology., 292, pp. 18-36.
316. La Du, B. N., 1996. “Structural and Function Diversity of Paraoxonases,” Natural
Medicine., 2, pp. 1186-1187.
317. Mackness, M. I., Mackness, B., Durrington, P. N., Connelly, P. W., Hegele, R. A.,
1996, “Paraoxonase: Biochemistry, Genetics and Relationship to Plasma
Lipoproteins,” Current Opinion in Lipidology., 7, pp. 69-76.
318. Ng, C. J., Wadleigh, D. J., Gangopadhay, A., Hama, S., Grijalva, V., Navab, M.,
2001, “Paraoxonase-2 is a Ubiquitously Expressed Protein with Antioxidant
Properties and is Capable of Preventing Cell-mediated Oxidative Modification of
178
Low Density Lipoprotein,” Journal of Biological Chemistry., 276, pp. 44444-
44449.
319. Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards,
P. A., 1995. “Atherosclerosis: Basic Mechanisms. Oxidation, Inflammation, and
Genetics,” Circulation., 91, pp. 2488-2496.
320. Migdalof, B. H., Antonaccio, M. J., McKinstry, D. N., Singhvi, S. M., Lan, S. J., Egli, P., Kripalani, K J., 1984. “Captopril: Pharmacology, Metabolism and
Disposition,” Drug Metabolism Reviews., 15, pp. 841-869.
321. Orhan, H., Marol, S., Hepsen, I. F., Sahin, G., 1999, “Effects of Some Probable
Antioxidants on Selenite-induced Cataract Formation and Oxidative Stress Related
Parameters in Rats,” Toxicology., 139, pp. 219-232.
322. Babizhayev, M. A., Deyev, A. I., Yermakova, V. N., Brikman, I. V., Bours, J.,
2004, “Lipid Peroxidation and Cataracts: N-acetylcarnosine as a Therapeutic Tool
to Manage Age-related Cataracts in Human and in Canine Eyes,” Drugs in R&D.,
5, pp. 125-139.
323. Fukiage, C., Azuma, M., Nakamura, Y., Tamada, Y., Shearer, T. R., 1998,
“Nuclear Cataract and Light Scattering in Cultured Lenses from Guinea Pig and
Rabbit,” Current Eye Research., 17, pp. 623-635.
324. Tripathi, B. J., Tripathi, R. C., Borisuth, N. S. C., Dhaliwal, R., Dhaliwal, D.,
1991, “Rodent Models of Congenital and Hereditary Cataract in Man,” Lens and
Eye Toxicity Research., 8, pp. 373-413.
325. Augusteyn, R. C., Stevens, A., 1998, “Macromolecular Structure of the Eye Lens,”
Progress in Polymer Science., 23, pp. 375-413.
326. Robertson, L. J., Morton, J. D., Yamaguchi, M., Bickerstaffe, R., Shearer, T. R.,
Azuma, M., 2005, “Calpain may Contribute to Hereditary Cataract Formation in
Sheep,” Investigative Ophthalmology and Visual Sciences., 46, pp. 4634-4640.
327. Lou, M. F., Dickerson, J. E., Jr., Garadi, R., 1990, “The Role of Protein-thiol
Mixed Disulfides in Cataractogenesis,” Experimental Eye Research., 50, pp. 819-
826.
328. Giblin, F. J., McCready, J. P., Schrimscher, L., Reddy, V. N., 1987, “Peroxide-
induced Effect on Lens Cation Transport Following Inhibition of Glutathione
Reductase Activity in vitro,” Experimental Eye Research., 45, pp. 77-91.
179
329. Smith, J. B., Jiang, X., Abraham, E. C., 1997, “Identification of Hydrogen
Peroxide Oxidation Sites of Alpha A- and Alpha B-crystallins,” Free Radical
Research., 26, pp. 103-111.
330. Shang, F., Gong, X., Taylor, A., 1997, “Activity of Ubiquitin-dependent Pathway
in Response to Oxidative Stress,” Journal of Biological Chemistry., 272, pp.
23086- 23093.
331. Li, W. C., Wang, G. M., Wang, R. R., Spector, A., 1994, “The Redox Active
Components H2O2 and N-acetyl-L-cysteine Regulate Expression of c-jun and c-fos
in Lens Systems,” Experimental Eye Research., 59, pp. 179-190.
332. Taylor, A., 1999, “Nutritional and Environmental Influences on Risk for Cataract”
In: Taylor, A., editor. “Nutritional and Environmental Influences on the Eye,”
CRC Press, Boca Raton, FL, pp. 53-93.
333. Szekeres, J., Pacsa, A. S., Pejtsik, B., 1981, “Measurement of Lymphocyte
Cytotoxicity by Assessing Endogenous Alkaline Phosphatase Activity of the
Target Cells,” Journal of Immunological Methods., 40, pp. 151-154.
334. Decker, T., Lohmann-Matthes, M. L., 1988, “A Quick and Simple Method for the
Quantitation of Lactate Dehydrogenase Release in Measurements of Cellular
Cytotoxicity and Tumor Necrosis Factor (TNF) Activity,” Journal of
Immunological Methods., 115, pp. 61-69.
335. Martin, A., Clynes, M., 1991, “Acid Phosphatase: Endpoint for in vitro Toxicity
Tests,” In Vitro Cell Development Biology., 27A, pp. 183-184.
336. David, L. L., Shearer, T. R., 1984, “State of Sulfhydryl in Selenite Cataract,”
Toxicology and Applied Pharmacology., 74, pp. 109-115.
337. Tietze, F., 1969, “Enzymatic Method for Quantitative Determination of Nanogram
Amounts of Total and Oxidised Glutathione: Applications to Mammalian Blood
and Other Tissues,” Analytical Biochemistry., 27, pp. 502-522.
338. Griffith, O. W., 1980, “Determination of Glutathione and Glutathione Disulfide
Using Glutathione Reductase and 2-vinylpyridine,” Analytical Biochemistry., 106,
pp. 207-212.
339. Ramachandran, S., Morris, S. M., Devamanoharan, P., Henein, M., Varma, S. D.,
1991, “Radio-isotopic Determination of Hydrogen Peroxide in Aqueous Humor
and Urine,” Experimental Eye Research., 53, pp. 503-506.
180
340. Giblin, F. J., McCready, J. P., Kodama, T., Reddy, V. N., 1984, “A Direct
Correlation Between the Levels of Ascorbic Acid and H2O2 in Aqueous Humor,”
Experimental Eye Research., 38, pp. 87-93.
341. Spector, A., Garner, W. H., 1981, “Hydrogen Peroxide and Human Cataract,”
Experimental Eye Research., 33, pp. 673-681.
342. Spector, A., Ma, W., Wang, R. R., 1998, “The Aqueous Humor is Capable of
Generating and Degrading H2O2,” Investigative Ophthalmology and Visual
Sciences., 39, pp. 1188-1197.
343. Cornish, K. M., Williamson, G., Sanderson, J., 2002, “Quercetin Metabolism in
the Lens: Role in Inhibition of Hydrogen Peroxide Induced Cataract,” Free
Radical Biology and Medicine., 33, pp. 63-70.
344. Zigler, J. S., Jernigan, H. M., Garland, D., Reddy, V. N., 1985, “The Effects of
"Oxygen Radicals" Generated in the Medium on Lenses in Organ Culture:
Inhibition of Damage by Chelated Iron,” Archives of Biochemistry and
Biophysics., 241, pp. 163-172.
345. Zigler, J. S., Lucas, V. A., Du, X. Y., 1989, “Rhesus Monkey Lens as an in
vitro Model for Studying Oxidative Stress,” Investigative Ophthalmology and
Visual Sciences., 30, pp. 2195-2199.
346. Clements, R. J., Bell, D. S., 1985, “Complications of Diabetes: Prevalence,
Detection, Current Treatment and Prognosis,” American Journal of Medicine., 79,
pp. 2-7.
347. Herman, W. H., Teutsch, S. M., Sepe, S. J., Sinnock, P., Klein, R., 1983, “An
Approach to the Prevention of Blindness in Diabetes,” Diabetes Care., 6, pp. 608-
613.
348. Ramana, B. V., Raju, T. N., Kumar, V. V., Reddy, P. U. M., 2007, “Defensive
Role of Quercetin Against Imbalances of Calcium, Sodium, and Potassium in
Galactosemic Cataract,” Biological Trace Elemental Research., 119, pp. 35-41.
349. Shukla, N., Moitra, J. K., Trivedi, R. C., 1996, “Determination of Lead, Zinc,
Potassium, Calcium, Copper and Sodium in Human Cataract Lenses,” The Science
of Total Environment., 181, pp. 161-165.
350. Saxena, P., Saxena, A. K., Cui, X. L., 2000, “Transition Metal-catalyzed
Oxidation of Ascorbate in Human Cataract Extracts: Possible Role of Advanced
Glycation End Products,” Investigative Ophthalmology and Visual Sciences., 41,
pp. 1473-1481.
181
351. Li-Na, H., Yi-Qun, L., Xiu-Mei, L., 2006, “Puerarin Decreases Lens Epithelium
Cell Apoptosis Induced Partly by Peroxynitrite in Diabetic Rats,” Acta
Physiologica Sinica., 58, pp. 584-592.
352. Kubo, E., Urakami, T., Fatma, N., 2004, “Polyol Pathway-dependent Osmotic and
Oxidative Stresses in Aldose Reductase-mediated Apoptosis in Human Lens
Epithelial Cells: Role of AOP2,” Biochemistry and Biophysics Research
Communication., 314, pp. 1050-1056.
353. Lam, H. C., Lee, J. K., Chiang, H. T., Chuang, M. J., Wang, M. C., 1998, “Is
Captopril Induced Improvement of Insulin Sensitivity Mediated via Endothelin?,”
Journal of Cardiovascular Pharmacology., 31, pp. 496-500.
354. Dal Ponte, D. B., fogt, D. L., Jacob, S., Henriksen, E. J., 1998, “Interactions of
Captopril and Verapamil on Glucose Tolerance and Insulin Action in an Animal
Model of Insulin Resistance,” Metabolism., 47, pp. 982-987.
355. Duarte, J., Martinez, A., Bermejo, A., 1999, “Cardiovascular effects of Captopril
and Enalapril in Obese Zucker Rats,” European Journal of Pharmacology., 365,
pp. 225-232.
356. Swislocki, A. L., Kinney, L. M., Khuu, T. L., Fann, D. T., Tait, K. Y., Rodnick, K.
J., 1999, “Metabolic, Hemodynamic, and Cardiac Effects of Captopril in Young,
Spontaneously Hypertensive Rats,” American Journal of Hypertension., 12, pp.
581-589.
357. Wiggam, M. I., Hunter, S. J., Atkinson, A. B., 1998, “Captopril does not Improve
Insulin Action in Essential Hypertension: A Double-Blind Placebo-Controlled
Study,” Journal of Hypertension., 16, pp. 1651-1657.
358. Naga Raju, T., Kanth Rajani, V., Lavanya, K., 2008, “Effect of Methanolic Extract
of Allium sativum (AS) in Delaying Cataract in STZ-induced Diabetic Rats,”
Journal of Ocular Biology, Diseases and Informatics., 1, pp. 46-54.
359. Follansbee, M. H., Beyer, K. H., Vesell, E. S., 1997, “Studies on
Pyrazinoylguanidine: Prevention of Cataracts in STZ-diabetic Rats,”
Pharmacology., 54, pp. 256-260.
360. West, C. D., Rapoport, S., 1949, “Colorimetric Method for the Estimation of
Dulcitol,” Proceedings of the Social and Experimental Biology., 70, pp. 142-145.
361. Lohr, G. W., Waller, H. D., 1965, “Determination of Glucose-6-phosphate
Dehydrogenase” In: Bergmeyer, H. U., editor. “Methods of Enzymatic Analysis,”
Academic Press, New York, pp. 744-751.
182
362. Beatly, C. M., Basinger, G. M., Dully, C. S., Bocek, R. M., 1966, “Comparison of
Red and White Voluntary Skeletal Muscles of Several Species of Primates,”
Journal of Histochemistry and Cytochemisrty., 14, pp. 590-600.
363. Bergmeyer, H. U., Berht, E., Hess, B., 1965, “Determination of Lactic
Dehydrogenase” In: Bergmeyer, H U., editor. “Methods of Enzymatic Analysis,”
Academic Press, New York, pp. 736-743.
364. Reeves, P. G., 1997, “Components of the AIN-93 Diets as Improvements in the
AIN-76A Diet,” Journal of Nutrition., 127, pp. 838S-841S.
365. Sippel, T. O., 1966, “Changes in the Water, Protein, and Glutathione Contents of
the Lens in the Course of Galactose Cataract Development in Rats,” Investigative
Ophthalmology., 5, pp. 568-575.
366. Van Heyningen, R., 1959, “Formation of Polyols by the Lens of the Rat with
Sugar Cataract,” Nature., 184, pp. 194.
367. Kinoshita, J. H., 1965, “Cataracts in Galactosemia: The Jonas S. Friedenwald
Memorial Lecture,” Investigative Ophthalmology., 4, pp. 786-799.
368. Van Heyningen R., 1959, “Metabolism of Xylose by the Lens. 2. Rat Lens in vivo
and in vitro,” Biochemistry Journal., 73, pp. 197-107.
369. Hockwin, O., Ohrloff, C., 1979, “Ageing of Lens Metabolism,” Ophthalmic
Research., 11, pp. 389-307.
370. Hockwin, O., Korte, I., 1968, In: Nordmann, J., Dardanne, M. U., editors.
“Biochemistry of the Eye,” S. Karger, Basel, pp. 216-221.
371. Rawal, U. M., Rao, G. M., 1980, “Enzymatic Studies on the Galactose Exposed
Lens,” Indian Journal of ophthalmology., 28, pp. 5-7.
372. Iwig, M., Glasser, D., Hieka, H., 1978, “Reactivation of Nucleus Containing Lens
Fibre Cells to Mitotic Growth Biochemical and Immunochemical Analysis,” Cell
Differentiation., 7, pp. 159-169.
373. Iwig, M., Glasser, D., 1972, “Investigations on Mitotic Activity, Cell Density, and
Enzyme Activities in the Bovine Eye during Cell Differentiation,” Ophthalmic
Research., 4, pp. 328-342.
374. Magaw, J. M., 1984. “Glutathione and Ocular Photobiology,” Current Eye
Research., 3, pp. 83-87.
APPENDIX 1